Feed KLRA
KL
Kailera Therapeutics, Inc.
KLRA · NASDAQ
$17.94 +0.06% (+$0.01)
1M -3.29%
Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
76 /100
Stable Beta 0.50x
EPS volatility N/A
Profitable years N/A
Întreabă StockBot despre KLRA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald C. Renaud Jr.
Employees
145
Headquarters
Waltham